Nimish P. Shah
Director · Cyclerion Therapeutics, Inc.
IndividualBuying only
- 2025
- Sep 10, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Nimish P. Shah files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Fairmount Funds Management LLC - $133.53M in APGE purchases and sales in the last 12 months
- Michael Thomas Henderson - $26.88M in APGE purchases and sales in the last 12 months
- Carl Dambkowski - $8.50M in APGE purchases and sales in the last 12 months
- Jane Henderson - $1.36M in APGE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Nimish P. Shah?
Nimish P. Shah is a corporate insider, tracked as Director of Cyclerion Therapeutics, Inc. (CYCN). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Nimish P. Shah submitted recently?
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Has Nimish P. Shah been buying or selling stock?
Recorded transactions: 1 open-market purchase ($15.00M) and 0 open-market sales across all tracked filings.
